Nicholas J. Diamond
Senior Manager, Avalere Health, Adjunct Professor of Law
A.B., LL.M., Georgetown; J.D., Charleston; M.B.E., University of Pennsylvania
Nicholas J. Diamond is a member of the Policy Practice at Avalere Health, where he advises biopharmaceutical companies, health insurers, advocacy organizations, and private equity...Continue Reading
Nicholas J. Diamond is a member of the Policy Practice at Avalere Health, where he advises biopharmaceutical companies, health insurers, advocacy organizations, and private equity firms on the current health policy and regulatory environment. He is also an adjunct faculty member in the Department of Health Policy and Management at George Washington and an adjunct fellow at the University of Pennsylvania’s Center for Public Health Initiatives.
Before joining Avalere, Professor Diamond led market strategy in the healthcare and life sciences sectors at MarkLogic, a global technology company headquartered in Silicon Valley. Before that, Professor Diamond held consulting roles at the MITRE Corporation and Booz Allen Hamilton, where he advised the federal government on policy and regulatory matters related to implementation of the Affordable Care Act.
Professor Diamond’s research spans issues at the intersection of health law, policy, and ethics, and has appeared in law reviews, peer-reviewed academic journals, and popular media outlets. He has lectured in a variety of academic and nonacademic settings, and appeared on a number of national news programs as an expert in public health law.
Professor Diamond spent his undergraduate years at Georgetown, after which he received a law degree from Charleston Law, where he was a Presidential Scholar in conjunction with the Medical University of South Carolina, served on the editorial board of one of the School’s law journals, and was recognized for his pro bono legal service to the community. He also holds a master’s degree in bioethics (M.B.E.) from the University of Pennsylvania, as well as a master of laws (LL.M.), with distinction and Dean’s List, in global health law from Georgetown Law, where he served as an Articles Editor and member of the Article Review Committee for The Food and Drug Law Journal.